Development of cyclosporin A mediated immunity in L1210 leukaemia

This publication has 17 references indexed in Scilit:

• SUCCESSFUL INVITRO GRAFT-VERSUS-TUMOR EFFECT AGAINST AN IA-BEARING TUMOR USING CYCLOSPORINE-INDUCED SYNGENEIC GRAFT-VERSUS-HOST DISEASE IN THE RAT
  1989
• IMPORTANCE OF LYT-2+ T-CELLS IN THE RESISTANCE OF MELPHALAN-CURED MOPC-315 TUMOR BEARERS TO A CHALLENGE WITH MOPC-315 TUMOR-CELLS
  1988
• Thymus and autoimmunity. Transplantation of the thymus from cyclosporin A-treated mice causes organ-specific autoimmune disease in athymic nude mice.
  The Journal of Experimental Medicine, 1988
• Cyclosporin A corrects daunorubicin resistance in Ehrlich ascites carcinoma
  British Journal of Cancer, 1986
• Cyclosporin A reverses vincristine and daunorubicin resistance in acute lymphatic leukemia in vitro.
  Journal of Clinical Investigation, 1986
• Development of graft-vs.-host disease-like syndrome in cyclosporine-treated rats after syngeneic bone marrow transplantation. I. Development of cytotoxic T lymphocytes with apparent polyclonal anti-Ia specificity, including autoreactivity.
  The Journal of Experimental Medicine, 1985
• Effect of cyclosporin A on human lymphocyte responses in vitro. I. CsA allows for the expression of alloantigen-activated suppressor cells while preferentially inhibiting the induction of cytolytic effector lymphocytes in MLR.
  The Journal of Immunology, 1980
• T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor.
  The Journal of Experimental Medicine, 1980
• Studies of Immunity in Mice Surviving Systemic Leukemia L1210
  JNCI Journal of the National Cancer Institute, 1960
• Prolongation of the Lifespan of Mice With Advanced Leukemia (L1210) by Treatment With Halogenated Derivatives of Amethopterin
  JNCI Journal of the National Cancer Institute, 1959